IHEC welcomes two new European member projects

May 10, 2017

Following the successful completion of BLUEPRINT last September, IHEC is happy to officially welcome the two new European projects MultipleMS and SYSCID to the consortium.

Both projects have been launched on 1 February 2017, and will receive close to 15 million euros each over the next five years. While MultipleMS aims to develop, validate, and exploit methods for patient stratification in Multiple Sclerosis, SYSCID focuses on multidimensional biomarker interpretation from blood and stool for a personalised approach to inflammatory bowel disease, rheumatoid arthritis and systemic lupus erythematosus.

“BLUEPRINT has been a cornerstone of IHEC for the past years, so we are of course very pleased to see a continuation of this active engagement by our European colleagues in the years ahead. The research teams behind MultipleMS and SYSCID will strengthen our consortium and significantly contribute to our future activities, particularly as IHEC has already started to shift its focus from data generation towards increased integrative analyses and comprehensive data assessment,” said Dr Eric Marcotte from the Canadian Institutes of Health Research (CIHR) and Chair of the IHEC Executive Committee.

For further information on the projects, please visit: